Aligos Therapeutics (ALGS) vs Elutia (ELUT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Elutia (ELUT) has outperformed Aligos Therapeutics (ALGS) over the past year, losing 6.5% versus a loss of 45.9%. Over five years, ELUT leads with a -85.0% price change compared with -98.7% for ALGS. Elutia is the larger company by market cap ($36.6 million vs $33.2 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ALGS | ELUT |
|---|---|---|
| Share price | $5.31 | $0.8273 |
| Market cap | $33.16M | $36.64M |
| 1-day change | -0.19% | +0.88% |
| YTD return | -42.92% | +18.34% |
| 1-year return | -45.93% | -6.49% |
| 5-year return | -98.66% | -84.95% |
| EPS (TTM) | $-7.41 | $-0.64 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $13.69 | $1.39 |
| 52-week low | $3.98 | $0.50 |
| Distance from 52-week high | -61.21% | -40.27% |
| Average volume | 91.45K | 184.45K |
| Shares outstanding | 5.44M | 44.29M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ELUT has outperformed ALGS by 39.4 percentage points over the past year.
ALGS vs ELUT FAQ
Which is bigger, Aligos Therapeutics or Elutia?
Elutia (ELUT) is larger, with a market capitalization of $36.64M compared with $33.16M for Aligos Therapeutics (ALGS).
Which stock has performed better over the past year, ALGS or ELUT?
ELUT returned -6.49% over the past 12 months, compared with -45.93% for ALGS (price return, excluding dividends). Past performance does not predict future results.
Are Aligos Therapeutics and Elutia in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.